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Role of cytology accompanied by the study of the occurrence of 
p16INK4a and O6-methylguanine-DNA transferase (MGMT) 
promoter methylation in the cells of the pleural cavity washings 
fluid in early diagnostics of non-microcellular lung caner (NSCLC) 
metastatic changes into pleura
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Background: Metastases of NSCLC into pleura are a wrong prognos-
tic index. Sometimes, it is possible to detect presence of metastases 
in pleural effusion before surgical treatment. It is very importance to 
exclude the risk of surgery in these patients. The aim of the study was 
to determine whether the washing of pleural cavity can help in early 
detection of NSCLC metastases into pleura. Additionally aberrant 
promoter methylation of p16INK4a and MGMT of pleural lavage cells 
were examined. 
Methods: Pleural lavage ﬂuid were collected from 32 patients (aged 48 
- 77 yrs) operated on NSCLC (studied group) and 6 patients (aged 30 
-71 yrs) operated for other reasons (control group). Promoter methyla-
tion status was examined in 27 cases by using methylation-speciﬁc 
polymerase chain reaction (MSP). Results of cytological studies and 
MSP examination were analyzed according to NSCLC histological 
type, TNM stage and localization of neoplastic foci in pleural.
Results: There were 50% patients with I stage NSCLC, 19% with II 
stage and 31% with III stage. Squamous cell carcinoma was diagnosed 
in 13 cases, adenocarcinoma in 14 and large cell carcinoma in 3 cases. 
Presence of neoplastic inﬁltrations into visceral pleura was detected by 
histological examination in 34% patients and parietal pleural in 16% 
patients. Cytological results of pleural cavity washing ﬂuid were posi-
tives in 4 cases, negatives in 21 cases and doubtful in 7 cases. Aber-
rant methylation of p16INK4a and MGMT genes was discovered in 
22 patients. There were not signiﬁcance differences between presence 
of neoplastic cells in lavage ﬂuid and type of cancer, TNM staging or 
pleural cancer inﬁltration. Aberrant methylation was more frequent in 
studied group (p=0,0003). There were not dependence between aber-
rant methylation and type of cancer, advanced TNM staging, presence 
of pleural neoplastic foci.
Conclusions: Cytology and analysis of p16INK4a and MGMT meth-
ylation of pleural cavity washings ﬂuid seem to be a promising exami-
nations in early detection of NSCLC metastases into pleura. 
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Tissue content of Suvivin mRNA and Survivin Expression in 
nonsmall cell lung cancer for diagnosis and prognosis.
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Background: Deregulation of apoptosis pathway is one of crucrial 
mechanisms causing tumorigenesis and driving cancer progression. 
Survivin is a member of the inhibitor of apoptosis, IAP gene family. It 
plays a dual role in both cell death suppression and cell cycle regula-
tion at the G2/M phase. Its expression also contributes to resistance to 
chemo- and radiotherapy of the cancer cells.
Objectives: This study was aimed at determination of surviving mRNA 
expression semiquantitatively comparing to the surviving expression 
in tumor tissue of the nonsmall cell lung cancer. Correlation between 
survivin mRNA content and expression of the commercially avail-
able survivin in the tumor tissue and pathlogical parameters is also 
evaluated proving the signiﬁcance of survivin in cancer diagnosis and 
prognosis.
Materials and Methods: 22 cases of surgically resected nonsmall cell 
lung cancer were included during the year 2005 and the early 2006. 
Total RNA was extracted from fresh frozen tissues of both cancer and 
corresponding normal lung tissues. The formalin-ﬁxed, parafﬁn-embed-
ded cancer tissue has been tested with commercially available suvivin 
antibody immunohistochemcially. The correlation between mRNA 
expression and protein expression was evaluated with pathological 
parameters using Chi-squre test. 
Conclusions: Selective survivin expression in the lung cancer tissue 
not in the normal lung tissue makes it a potential diagnostic marker 
however, the prognostic marker to select the cases that might be che-
moresponsive needs to verify with the other markers. 
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Background: We used the differential display RT-PCR method using 
various types of normal human lung tissues, lung cancer cell line, and 
lung cancer tissues and then identiﬁed three hundred unique oncogenes 
overexpressed in human lung cancer tissues. The objective of this study 
was to investigate the signiﬁcance of these newly identiﬁed oncogenes 
as candidate tumor markers for the human lung cancers.
Methods: Northern blot analysis showed that identiﬁed three hundred 
oncogenes were overexpessed in human lung cancer tissues compared 
to normal lung tissues, respectively. Recombinant oncoproteins were 
overproduced in E. coli and puriﬁed. Using these as immunogens, more 
than 100 monoclonal antibodies and each rabbit polysera were gener-
ated. Tumorous tissues and their corresponding non-tumorous tissues 
from cancer patients who underwent surgical resection were examined 
for the expression of each new oncoprotein using immunohistochemi-
cal staining and Western blot, respectively. 
Results: Each polyclonal antibody and monoclonal antibody reacted 
strongly and speciﬁcally with new respective oncoprotein was used for 
the biochemical and immunohistochemical studies. The expressions of 
each new oncoprotein were signiﬁcantly observed in the tumorous por-
tion of human lung cancers. 
Conclusions: Our study suggests that newly developed cancer-spe-
ciﬁc antibodies will facilitate the assessment of human lung cancers in 
tumor diagnostic histopathology and may be useful as speciﬁc tumor 
markers against human lung cancers.
